ArticlePDF Available

Translocation of Inhaled Ultrafine Particles to the Brain

Authors:

Abstract and Figures

Ultrafine particles (UFP, particles <100 nm) are ubiquitous in ambient urban and indoor air from multiple sources and may contribute to adverse respiratory and cardiovascular effects of particulate matter (PM). Depending on their particle size, inhaled UFP are efficiently deposited in nasal, tracheobronchial, and alveolar regions due to diffusion. Our previous rat studies have shown that UFP can translocate to interstitial sites in the respiratory tract as well as to extrapulmonary organs such as liver within 4 to 24 h postexposure. There were also indications that the olfactory bulb of the brain was targeted. Our objective in this follow-up study, therefore, was to determine whether translocation of inhaled ultrafine solid particles to regions of the brain takes place, hypothesizing that UFP depositing on the olfactory mucosa of the nasal region will translocate along the olfactory nerve into the olfactory bulb. This should result in significant increases in that region on the days following the exposure as opposed to other areas of the central nervous system (CNS). We generated ultrafine elemental (13)C particles (CMD = 36 nm; GSD = 1.66) from [(13)C] graphite rods by electric spark discharge in an argon atmosphere at a concentration of 160 microg/m(3). Rats were exposed for 6 h, and lungs, cerebrum, cerebellum and olfactory bulbs were removed 1, 3, 5, and 7 days after exposure. (13)C concentrations were determined by isotope ratio mass spectroscopy and compared to background (13)C levels of sham-exposed controls (day 0). The background corrected pulmonary (13)C added as ultrafine (13)C particles on day 1 postexposure was 1.34 microg/lung. Lung (13)C concentration decreased from 1.39 microg/g (day 1) to 0.59 microg/g by 7 days postexposure. There was a significant and persistent increase in added (13)C in the olfactory bulb of 0.35 microg/g on day 1, which increased to 0.43 microg/g by day 7. Day 1 (13)C concentrations of cerebrum and cerebellum were also significantly increased but the increase was inconsistent, significant only on one additional day of the postexposure period, possibly reflecting translocation across the blood-brain barrier in certain brain regions. The increases in olfactory bulbs are consistent with earlier studies in nonhuman primates and rodents that demonstrated that intranasally instilled solid UFP translocate along axons of the olfactory nerve into the CNS. We conclude from our study that the CNS can be targeted by airborne solid ultrafine particles and that the most likely mechanism is from deposits on the olfactory mucosa of the nasopharyngeal region of the respiratory tract and subsequent translocation via the olfactory nerve. Depending on particle size, >50% of inhaled UFP can be depositing in the nasopharyngeal region during nasal breathing. Preliminary estimates from the present results show that approximately 20% of the UFP deposited on the olfactory mucosa of the rat can be translocated to the olfactory bulb. Such neuronal translocation constitutes an additional not generally recognized clearance pathway for inhaled solid UFP, whose significance for humans, however, still needs to be established. It could provide a portal of entry into the CNS for solid UFP, circumventing the tight blood-brain barrier. Whether this translocation of inhaled UFP can cause CNS effects needs to be determined in future studies.
Content may be subject to copyright.
Inhalation Toxicology, 16:437–445, 2004
Copyright
c
Taylor & Francis Inc.
ISSN: 0895-8378 print / 1091-7691 online
DOI: 10.1080/08958370490439597
Translocation of Inhaled Ultrafine Particles to the Brain
G. Oberd¨orster
University of Rochester, Rochester, New York, USA
Z. Sharp, V. Atudorei
University of New Mexico, Albuquerque, New Mexico, USA
A. Elder, R. Gelein
University of Rochester, Rochester, New York, USA
W. Kreyling
National Research Center for Environment and Health (GSF), Neuherberg/Munich, Germany
C. Cox
National Institutes of Health, Bethesda, Maryland, USA
Ultrafine particles (UFP, particles <100 nm) are ubiquitous in ambient urban and indoor air
from multiple sources and may contribute to adverse respiratory and cardiovascular effects of
particulate matter (PM). Depending on their particle size, inhaled UFP are efficiently deposited
in nasal, tracheobronchial, and alveolar regions due to diffusion. Our previous rat studies have
shown that UFP can translocate to interstitial sites in the respiratory tract as well as to extrapul-
monary organs such as liver within 4 to 24 h postexposure. There were also indications that the
olfactory bulb of the brain was targeted. Our objective in this follow-up study, therefore, was
to determine whether translocation of inhaled ultrafine solid particles to regions of the brain
takes place, hypothesizing that UFP depositing on the olfactory mucosa of the nasal region will
translocate along the olfactory nerve into the olfactory bulb. This should result in significant in-
creases in that region on the days following the exposure as opposed to other areas of the central
nervous system (CNS). We generated ultrafine elemental
13
C particles (CMD = 36 nm; GSD =
1.66) from [
13
C] graphite rods by electric spark discharge in an argon atmosphere at a concen-
tration of 160 µg/m
3
. Rats were exposed for 6 h, and lungs, cerebrum, cerebellum and olfactory
bulbs were removed 1, 3, 5, and 7 days after exposure.
13
C concentrations were determined
by isotope ratio mass spectroscopy and compared to background
13
C levels of sham-exposed
controls (day 0). The background corrected pulmonary
13
C added as ultrafine
13
C particles on
day 1 postexposure was 1.34 µg/lung. Lung
13
C concentration decreased from 1.39 µg/g (day 1)
to 0.59 µg/g by 7 days postexposure. There was a significant and persistent increase in added
13
C
in the olfactory bulb of 0.35 µg/g on day 1, which increased to 0.43 µg/g by day 7. Day 1
13
C con-
centrations of cerebrum and cerebellum were also significantly increased but the increase was
inconsistent, significant only on one additional day of the postexposure period, possibly reflecting
translocation across the blood–brain barrier in certain brain regions. The increases in olfactory
bulbs are consistent with earlier studies in nonhuman primates and rodents that demonstrated
that intranasally instilled solid UFP translocate along axons of the olfactory nerve into the CNS.
We conclude from our study that the CNS can be targeted by airborne solid ultrafine particles
and that the most likely mechanism is from deposits on the olfactory mucosa of the nasopha-
ryngeal region of the respiratory tract and subsequent translocation via the olfactory nerve.
Received 21 July 2003; sent for revision 13 August 2003; accepted 22 September 2003.
This work was supported by the U.S. Environmental Protection Agency STAR Program, grant R827354, and by NIEHS grant ESO1247. We
acknowledge the excellent technical assistance of N. Corson, P. Mercer, and A. Lunts, and the valuable editorial assistance of J. Havalack. The
views expressed by the authors are their own and do not necessarily reflect those of the U.S. EPA.
Address correspondence to Dr. G¨unter Oberd¨orster, Department of Environmental Medicine, University of Rochester, 575 Elmwood Avenue,
Med. Ctr. Box 850, Rochester, NY 14642, USA. E-mail: gunter
oberdorster@urmc.rochester.edu
437
438 G. OBERD
¨
ORSTER ET AL.
Depending on particle size, >50% of inhaled UFP can be depositing in the nasopharyngeal
region during nasal breathing. Preliminary estimates from the present results show that 20%
of the UFP deposited on the olfactory mucosa of the rat can be translocated to the olfactory
bulb. Such neuronal translocation constitutes an additional not generally recognized clearance
pathway for inhaled solid UFP, whose signicance for humans, however, still needs to be estab-
lished. It could provide a portal of entry into the CNS for solid UFP, circumventing the tight
bloodbrain barrier. Whether this translocation of inhaled UFP can cause CNS effects needs to
be determined in future studies.
Ultrane particles (UFP, particles <100 nm) are ubiquitous
in the ambient air, both indoor and outdoor, originating from
many anthropogenic and natural sources. Several epidemio-
logical studies have shown that ambient UFP are associated
with increased respiratory and cardiovascular morbidity and
mortality in susceptible people (Wichmann et al., 2000; Peters
et al., 1997a, 1997b; Penttinen et al., 2001; von Klot et al.,
2002; Pekkanen et al., 2002). The deposition of inhaled UFP
in the respiratory tract is governed by diffusional processes,
yet there are signicant differences within the ultrane particle
size range with respect to the efciency of their maximal de-
position in different regions of the respiratory tract, as depicted
in Figure 1. About 90% of inhaled UFP around 1 nm in size
deposit in the nasopharyngeal region (Swift et al., 1992; Cheng
et al., 1996), whereas only about 10% of this size deposit in
the tracheobronchial and essentially none in the alveolar re-
gion; in contrast, 5- to 10-nm UFP deposit in all 3 regions with
about 2030% efciency, whereas 20-nm UFP are predicted to
be deposited in the alveolar region up to 50% and only about
10% each in the nasopharyngeal and tracheobronchial regions
FIG. 1. ICRP (1994) model of fractional depositions of in-
haled particles ranging from 0.6 nm to 20 µm in the na-
sopharyngeal/laryngeal (NPL), the tracheobronchial (TB), and
the alveolar (A) regions of the human respiratory tract dur-
ing nasal breathing. Note that within the ultrane particle size
range (<100 nm) there are signicant differences in each of the
3 regions with regard to their deposition probabilities.
(ICRP, 1994). Thus, each of the three regions of the respiratory
tract is targeted differently by a given size of UFP (Figure 1).
Their fate after deposition seems to differ from that of larger
particles, at least as far as solid or poorly soluble UFP are con-
cerned. We have found that within 4 h after whole-body inhala-
tion exposure of rats, ultrane polytetrauoroethylene (PTFE)
particles (CMD 20 nm) had translocated to submucosal sites
of the conducting airways and to the pulmonary interstitium of
the alveolar region (Oberd¨orster et al., 2000). Other rat inhala-
tion studies have shown that ultrane elemental
13
C particles
(CMD 30 nm) had accumulated to a large degree in the liver
of rats by 24 h after exposure, indicating efcient translocation
into the blood circulation (Oberd¨orster et al., 2002). Suggested
pathways into the blood could be across the alveolar epithelium
as well as across intestinal epithelium from particles swallowed
into the gastrointestinal (GI) tract. On the other hand, using a
method of intratracheal inhalation of ultrane
192
Ir particles in
rats, Kreyling et al. (2002) found only minimal translocation
(<1%) from the lung to extrapulmonary organs, although they
reported 10-fold higher translocation of smaller (15 nm) com-
pared to larger (80 nm) UFP. Nemmar et al. (2002) reported
ndings in humans that inhalation of
99m
Tc-labeled ultrane
carbon particles (Technegas) resulted in the rapid appearance
of the label in the blood circulation shortly after exposure and
also in the liver. They suggested that this at least partly indi-
cated translocation of inhaled UFP into the blood circulation.
In contrast, other studies in humans with
99m
Tc-labeled car-
bon particles (33 nm) by Brown et al. (2002) did not conrm
such uptake into the liver, and the authors cautioned that the
ndings by Nemmar et al. (2002) were likely due to soluble
pertechnetate rather than labeled UFP.
It appears, therefore, that UFP size and chemistry (e.g., car-
bon vs. metal) are important determinants for extrapulmonary
translocation of UFP. We had observed in an earlier pilot study
with inhaled ultrane
13
C particles a signicant increase of
13
C in the olfactory bulb of rats, which led us to hypothesize
that routes for extrapulmonary translocation of solid UPF other
than via the blood circulation exist, that is, involving neuronal
pathways from deposits on the nasal olfactory mucosa via the
olfactory nerve. We decided, therefore, to conduct a more de-
tailed study in rats with a follow-up period of 7 days after UFP
inhalation for measuring their retention in lung and different
brain sections. We report here the signicant accumulation of
13
C in the olfactory bulb over the 7-day postexposure period,
suggesting that a most likely pathway of translocation of solid
ULTRAFINE PARTICLE TRANSLOCATION TO THE BRAIN
439
UFP from the upper respiratory tract is indeed via the olfactory
nerve.
METHODS
Generation of Particles
Ultrane
13
C particles were generated from pure [
13
C]
graphite electrodes placed in an electric spark discharge gen-
erator supplied with argon in the discharge chamber (Palas
soot generator, Karlsruhe, Germany). The [
13
C]graphite elec-
trodes were made by extruding a slurry of amorphous
13
Cpow-
der (Isotec, Inc., Miamisburg, OH) mixed with [
13
C
6
]glucose
(Isotec, Inc., Miamisburg, OH) through a syringe to produce
3.5-mm-diameter cylinders. These were baked in an argon at-
mosphere by slowly ramping up the temperature to 200
C
within 1.5 h in order to degas the extrusion and decompose
the glucose. The electrodes were subsequently graphitized at
2400
C in argon.
13
C Measurement
Isotopic measurements were performed by continuous-ow
isotope ratio mass spectrometry (Brand, 1996), using a Carlo
Erba elemental analyzer coupled to a Finnigan Mat Delta Plus
mass spectrometer. The results are reported using the conven-
tional δ notation, relative to the PDB standard (fossilized calcite
standard), expressed as per mille change:
δ-
13
C =
13
C/
12
C
sample
13
C/
12
C
standard
13
C/
12
C
standard
× 1000 [1]
where
13
C/
12
C
standard
is the ratio of the reference material (PDB)
and
13
C/
12
C
sample
is the ratio of the sample. Reproducibility
was better than 0.1 for both standards and samples, which
translates into a detection limit of about 1 ppm of added
13
C
(the
13
C/
12
C ratio for PDB is 0.0112372). Since mammalian
tissues have a lower
13
C/
12
C ratio than the reference carbonate,
the δ-
13
C values are negative.
Animal Exposure and Particle Characterization
Male Fischer-344 rats, 14 wk old, at a body weight of 284 ±
9 g, were used for the study. The exposure was for6hin
compartmentalized whole-body exposure chambers and was
performed in 2 sessions. Particle number concentration in the
inhalation chamber was measured by a condensation nuclei
counter (TSI model 3022A), and ultrane particle size distri-
bution by a scanning mobility particle sizer (SMPS, TSI model
3080). Particle mass concentration was determined by an ambi-
ent particulate monitor (TEOM, model series 1400a, Rupprecht
and Patashnik, Albany, NY). Six rats were exposed in the rst
session at a concentration of 170 µg ultrane
13
C particles/m
3
(CMD = 37 nm; GSD [geometric standard deviation] = 1.66)
and were sacriced on days 1 and 3 postexposure. An additional
6 rats were exposed in the second session at a concentration of
150 µg ultrane
13
C particles/m
3
(CMD = 35 nm; GSD = 1.66)
and were sacriced on days 5 and 7 postexposure, using 3 rats
per time point. Three unexposed rats served as controls.
Organ Preparation and
13
C Analysis
At 1, 3, 5, and 7 days postexposure, rats were sacriced and
lung, olfactory bulb, cerebrum, and cerebellum were removed
for
13
C analysis. The excised organs were weighed. Great care
was taken to avoid contamination of the organs with
13
C that
had deposited on the fur of the animals. To achieve this, the ani-
mals were killed by an overdose of intraperitoneal pentobarbital
and the fur was wet-wiped with clean tissues. Subsequently the
animals were completely skinned and the carcasses were rinsed
under water. The carcasses were then moved to a separate clean
room and organs were excised there with different clean sets of
instruments. The cranium was opened and the cerebrum, cere-
bellum, and olfactory bulbs were carefully removed. Each of
the organs was homogenized with different clean homogenizers
and subsequently lyophilized. Unexposed control animals were
treated the same way; they were killed prior to sacricing the
day 1 exposed rats. Two 1-mg aliquots of each organ sample
were used for δ-
13
C value determinations using continuous-
ow mass spectroscopy for 36 replicate measurements. Re-
sults were subjected to a weighted two-way analysis of variance
(ANOVA), with signicant increases in δ-
13
C values being de-
ned when p <.05. The two factors in the ANOVA were expo-
sure group and time. The observations were means of replicate
measurements, and the number of replications was used as the
weight.
The difference in δ-
13
C between organs of exposed rats and
the average of respective organs of control rats was used to
calculate the added
13
C organ burden. In order to translate δ-
13
C
values into absolute amounts of
13
C added to each organ (excess
13
C), the baseline carbon contentthat is, the sum of
12
C and
13
Cof the different organs needs to be known. Such baseline
levels are summarized for humans as Reference Man values by
ICRP (1992). For example, lung total carbon content is 10% of
lung weight, and an average value for brain total carbon content
is 12.2% of brain weight. Assuming that the carbon content
of organs in rats and humans is the same or very similar, the
baseline
13
C can be determined using the Reference Man data.
These baseline values were used to quantify the added
13
Cin
exposed compared to control animals.
RESULTS
Table 1 shows the results of the δ-
13
C measurements in
lungs and the different sections of the brain of control rats,
and of exposed rats on days 1, 3, 5, and 7 postexposure. The
lungs display the expected signicant increase in δ-
13
C from
20.28 in controls to 19.04 on day 1. A more than 50% de-
crease on subsequent days to 19.75 by day 7 follows, still
signicantly above controls. δ-
13
C for the olfactory bulb was
also signicantly elevated on all postexposure days, from a
baseline value of 18.91 (controls) to 18.66 (day 1) and
to 18.60 (day 7), reecting the largest increase on day 1
440 G. OBERD
¨
ORSTER ET AL.
TABLE 1
δ-
13
C Values and excess
13
C levels of lung and brain tissues following6hofultrane
13
C particle exposure (mean ± SD, n = 3
per time point)
Postexposure
Unexposed control;
day 0 Day 1 Day 3 Day 5 Day 7
Lung
δ-
13
C 20.28 ± 0.27 19.04 ± 0.23
a
19.14 ± 0.24
a
19.54 ± 0.14
a
19.75 ± 0.14
a
µg 0.01 ± 0.3 1.34 ± 0.22 1.40 ± 0.31 0.80 ± 0.17 0.64 ± 0.16
µg/g 0.0 ± 0.3 1.39 ± 0.26 1.28 ± 0.27 0.83 ± 0.16 0.59 ± 0.15
Olfactory bulb
δ-
13
C 18.91 ± 0.09 18.66 ± 0.12
a
18.66 ± 0.01
a
18.64 ± 0.06
a
18.60 ± 0.06
a
µg 0.00 ± 0.01 0.03 ± 0.02 0.03 ± 0.00 0.03 ± 0.01 0.04 ± 0.01
µg/g 0.01 ± 0.12 0.35 ± 0.17 0.35 ± 0.02 0.37 ± 0.08 0.43 ± 0.08
Cerebrum
δ-
13
C 19.24 ± 0.04 19.04 ± 0.02
a
19.13 ± 0.09 19.16 ± 0.08 19.07 ± 0.01
a
µg 0.00 ± 0.07 0.32 ± 0.02 0.19 ± 0.16 0.14 ± 0.13 0.29 ± 0.02
µg/g 0.00 ± 0.05 0.27 ± 0.03 0.15 ± 0.13 0.11 ± 0.11 0.23 ± 0.02
Cerebellum
δ-
13
C 19.46 ± 0.08 19.14 ± 0.15
a
19.32 ± 0.07 19.19 ± 0.10
a
19.31 ± 0.14
µg 0.00 ± 0.03 0.12 ± 0.04 0.06 ± 0.03 0.10 ± 0.03 0.06 ± 0.06
µg/g 0.00 ± 0.10 0.44 ± 0.20 0.19 ± 0.09 0.37 ± 0.13 0.21 ± 0.19
a
Signicantly increased compared to controls, p <.05 (ANOVA).
and continuous slight increases thereafter. Cerebrum and cere-
bellum also showed increases of δ-
13
C postexposure, which,
however, was not consistent, and signicantly elevated only
on day 1 (both regions), day 5 (cerebellum), and day 7 (cere-
brum). The higher baseline values for δ-
13
C of the brain re-
gions compared to those in the lungs reect the greater carbon
content of brain tissues compared to that of the lung (ICRP,
1992).
Table 1 and Figure 2 show the results of excess
13
C in lung,
olfactory bulb, cerebrum, and cerebellum derived from the re-
spective δ-
13
C values. The day following the 6-h
13
C inhala-
tion exposure, an added lung concentration of 1.39 ± 0.26 µg
13
C/g lung was determined. By day 7, this concentration had
decreased to 0.59 ± 0.15 µg added
13
C/g lung. Added
13
C con-
centrations in the olfactory bulb were signicantly increased
throughout the postexposure period, increasing to 0.35 ±
0.17 µg/g tissue on day 1 and to 0.43 ± 0.08 µg/g tissue by
day 7. Added
13
C concentrations in cerebellum and cerebrum
were signicantly elevated only on 2 of the postexposure days,
reaching concentrations between 0.11 and 0.44 µg/g tissue.
Although by day 7 the olfactory bulb concentration of
13
C ap-
proached day 7
13
C concentrations in the lung, the total amount
accumulating in the olfactory bulb is only small; considering
its average weight of only 85 mg, the amount accumulating
in the olfactory bulb over 7 days was 40 ng (Table 1). This,
however, was achieved after a single exposure only, and since
no decrease in
13
C during the 7 days postexposure occurred,
continuous exposures are likely to reach much higher levels.
Due to the greater weight of cerebrum and cerebellum, their
total
13
C content on day 1 postexposure was calculated to be
10- and 4-fold higher compared to the olfactory bulb (Table 1).
However, this elevation was not consistently signicant over the
FIG. 2. Time course of
13
C tissue concentrations in lung, ol-
factory bulb, cerebrum, and cerebellum of rats following a 6-h
inhalation exposure to ultrane (36 nm CMD) elemental
13
C
particles (n = 3 rats per time point): ––lung;olfactory
–—–cerebellum; ··· cerebrum. Asterisk and a, b, c indicate
values signicantly greater than controls, p <.05 (ANOVA)
(asterisk for lung, a for olfactory bulb, b for cerebellum, c for
cerebrum).
ULTRAFINE PARTICLE TRANSLOCATION TO THE BRAIN
441
following days; it may well reect some localized higher accu-
mulation, which needs to be further investigated in subsequent
studies.
DISCUSSION
We found signicant and continuous increases of
13
C in the
olfactory bulb throughout the 7-day postexposure period fol-
lowing the 6-h inhalation exposure to ultrane elemental
13
C
particles with a CMD of 36 nm and GSD of 1.66. Cerebrum
and cerebellum also showed signicant increases on 2 of the
postexposure days. Since elemental carbon is insoluble (CRC
Press, 2000), these changes in
13
C concentration reect the ac-
cumulation and retention of the ultrane carbon particles in the
respective organs. Translocation of the inhaled ultrane carbon
particles to the CNS could occur principally via two pathway:
One is through access across the bloodbrain barrier (BBB) of
ultrane particles after their translocation into the blood circula-
tion from deposits anywhere in the respiratory tract; the other
specic for the olfactory bulbis via the olfactory nerve from
deposits on the nasal olfactory mucosa the third pathway is via
paracellular or perineural pathways across the olfactory mu-
cosa and ethmoid bone into cerebrospinal uid (CSF) (Illum,
2000). Although our present study was not designed to differ-
entiate between these three pathways, we offer the following
interpretation of our results based on available literature data.
Supportive of a circulatory route of UFP translocation from
deposits in the respiratory tract are results of our previous study
(Oberd¨orster et al., 2002). Signicant amounts of ultrane
13
C
accumulated in the liver by 24 h postexposure, which must be
a consequence of the ultrane carbon particles having translo-
cated into the blood circulation. Against the circulatory route
of CNS translocation of UFP speaks the fact that the BBB is
very tight, and studies with iv-injected UFP failed to demon-
strate their access into the CNS across this barrier (Gulyaev
et al., 1999) or across the tight distal barrier of the basal lam-
ina (Muldoon et al., 1999). Only after coating intravenously
injected nanoparticles with polysorbate or apolipoprotein did
they seem to mimic lipoprotein particles that could be taken
up by brain capillary endothelial cells via receptor-mediated
phagocytosis (Kreuter et al., 2002). Yet even then, transcyto-
sis of the nanoparticles across the BBB could not be demon-
strated. Particles translocating along paracellular or perineural
pathways into CSF would have to cross the CSF-brain barrier,
another functional barrier, and would not target specically the
olfactory bulb. Thus, the consistent postexposure increase of
13
C in the olfactory bulb is unlikely to be of blood-borne CSF
origin. It is conceivable, though, that the increase in
13
C in cere-
brum and cerebellum in our study reects some translocation
of solid UFP across the BBB in regions where epithelia are less
tight, such as the circumventricular organs, or across the blood-
CSF barrier, such as the choroid plexus, ventricles, brainstem
centers, and hypothalamus (Segal, 2000; Ueno et al., 2000).
Possible translocation from the blood circulation in these areas
may be associated with a very rapid clearance from the lung
early during the exposure of more than 50% of the UFP de-
positing in the lung. Such early rapid clearance was suggested
by the results of our previous study (Oberd¨orster et al., 2002)
based on the difference between measured and predicted lung
burden. The present study, too, shows a large difference be-
tween the predicted deposition of
13
C in the lung (2.93 µg)
and what was actually measured on day 1 (1.34 µg; Table 1),
which suggests, assuming that the model is correct, more than
50% elimination of pulmonary
13
C during the exposure phase.
If most of this is translocated into the blood circulation, some
transport across the less developed sections of the BBB con-
ceivably may occur. This could then account for the increased
13
C levels in cerebrum and cerebellum on day 1 postexposure.
However, since only the olfactory bulbs showed consistent and
increasing
13
C levels on all days in the 7-day postexposure pe-
riod, and cerebellum and cerebrum only on 1 day, we believe
that at least for the olfactory bulb, axonal transport of UFP via
olfactory neurons from nasal deposits into the CNS is the major
translocation mechanism.
The existence of an olfactory nerve pathway as access to
the CNS has been well demonstrated for inhaled or nasally in-
stilled soluble metal compounds (Tj¨alve & Henriksson, 1999;
Arvidson, 1994; Dorman et al., 2002). Since inhalation expo-
sure of UFP results in signicant deposition in the nasal area
of the rat, a reasonable interpretation of our result is that in-
haled solid UFP translocate via this route as well. In order to
prove that nasal deposits of UFP translocate to the olfactory
bulb, it would be most convincing to demonstrate the presence
of the ultrane
13
C particles in the axons of the olfactory neu-
rons. While our present study was limited in its design and
did not include dissection and analysis of olfactory nerves, the
older literature provides convincing evidence for such neuronal
translocation of solid UFP following intranasal instillations in
nonhuman primates and in rats.
De Lorenzo (1970) in a landmark study demonstrated in
squirrel monkeys that intranasally instilled colloidal gold par-
ticles (50 nm) translocated anterogradely in the axons of the
olfactory nerves to the olfactory bulbs. He used transmission
electron microscopy to image the sequence of the passage of
the 50-nm electron-dense particles along the whole pathway:
starting with their localization postinstillation on the olfactory
mucosa, followed by uptake into the olfactory rods of the nasal
mucosa (probably via endocytosis as evidenced by large num-
bers of pinocytotic vacuoles, which led the author to conclude
that the olfactory rod is busily engaged in drinking in from
the extracellular environment), retrograde translocation within
the olfactory dendrites likely associated with microtubuli,
anterograde movement in the axoplasm along the olfactory la
of the olfactory nerve, appearance in the olfactory bulb, and then
even showing the 50 nm gold particles having crossed synapses
This prediction is based on the multiple path particle deposition model
(Asgharian et al., 1999) with 0.55 µg
13
C-UFP depositing in the tracheo-
bronchial region and 2.38 µg in the alveolar region of the rats during the
6-h exposure.
442 G. OBERD
¨
ORSTER ET AL.
in the olfactory glomerulus to reach mitral cell dendrites within
1 h after intranasal instillation. An interesting nding in this
studyand important for potential adverse effectswas that
the UFP in the olfactory bulb were no longer freely distributed in
the cytoplasm but were preferentially located in mitochondria.
Remarkable also is the neuronal transport velocity of the 50 nm
gold particles, calculated by De Lorenzo to be 2.5 mm/h.
Other studies on olfactory translocation of solid UFP were
reported in the 1940s and concerned a large series of studies
with 30 nm polio virus intranasally instilled into chimpanzees
and Rhesus monkeys (Bodian & Howe, 1941; Howe & Bodian,
1941). Their studies revealed that the olfactory nerve and ol-
factory bulbs are, indeed, portals of entry to the CNS for the
intranasally-instilled ultrane polio virus particles, which could
subsequently be recovered from the olfactory bulbs. The trans-
port velocity of the virus in the axoplasm of axons was deter-
mined at 2.4 mm/h, which is very well in agreement with De
Lorenzos result, and also with neuronal transport velocities
measured later by Adams and Bray (1983) for solid particles
(up to 500 nm) directly microinjected into giant axons of crabs.
There are additional studies showing that sensory nerves
in the upper and lower respiratory tract can take up solid mi-
cro particles and translocate these. For example, a more re-
cent study by Hunter and Dey (1998) in rats demonstrated the
translocation of intranasally instilled rhodamine-labeled micro-
spheres (20200 nm) to the trigeminal ganglion inside the cra-
nium via uptake into the ophthalmic and maxillary neurons of
the trigeminus nerve. The trigeminus supplies sensory nerve
endings throughout the nasal mucosa, including the olfactory
mucosa (Shankland, 2001; Schaefer et al., 2002). Hunter and
Undem (1999) in a different study instilled the same micropar-
ticles intratracheally into guinea pigs. They found that sensory
nerves supplying the tracheobronchial region with a dense net-
work can take up and translocate these solid microparticles to
the ganglion nodosum in the neck area, which is networked into
the vagal system. Their method of tracing neuronal pathways
had been developed by Katz et al. (1984), who had shown that
these rhodamine-labeled microparticles (30 nm may be the op-
timal size; Katz, personal communication) translocated along
axons and dendrites when microinjected into cortical sections
of rats and cats.
Collectively, these studies show that solid UFP of different
materials can effectively be taken up by sensory nerve endings
at several sites in the respiratory tract and gain access to the
CNS and ganglionic structures. In particular, the studies by De
Lorenzo (1970) demonstrate unequivocally the existence of a
neuronal olfactory pathway to the CNS for nasally deposited
solid UFP. Since inhaled UFP are deposited to a signicant
degree in the nasal region of the respiratory tract of the rat
(Gerde et al., 1991), a most likely mechanism to explain the
13
C accumulation in the olfactory bulb of rats in our inhalation
study is via the olfactory neuronal route. Possibly, differences
in the physicochemical nature of UFP may inuence such
translocation.
In an attempt to quantify the translocation of
13
C particles
along this pathway in our study we considered the following:
Nasal deposition studies of ultrane particles in rats showed that
the deposition efciency for 42-nm particles is 10.5% (Gerde
et al., 1991). The CMD of the ultrane
13
C particles in our
study was 36 nm, with a geometric standard deviation of 1.66.
A recently developed particle deposition model (MPPD, multi-
ple path particle deposition; Asgharian et al., 1999) predicts for
the rat that at this particle size distribution 9.4% of the inhaled
particles will deposit in the nasal compartment, including the
nasal olfactory mucosa close to the measured value by Gerde
et al. (1991). Under our specic study conditions, this amounts
to 1.10 µg of ultrane
13
C particles, which is almost as much
as was measured in the lung. Since only 15% of the total air-
ow is directed to the olfactory mucosa in rats (Kimbell et al.,
1997), the predicted deposited amount of
13
C in this area may
only be 165 ng, 15% of the total nasal deposit. Assuming that
the amount of
13
C measured in the olfactory bulb (3040 ng,
Table 1) was translocated along the olfactory neuronal route,
this would mean that 20% of the deposited amount on the ol-
factory mucosa was translocated to the olfactory bulb over the
7-day postexposure period. There are probably signicant un-
certainties around this estimate and therefore it has to be viewed
with caution. Additional studies using more sensitive methods
of detection are required to verify translocation pathways and
more precisely quantitate neuronal translocation efciency of
inhaled UFP.
Considering that only 5% of the human nasal mucosa is ol-
factory epithelium as opposed to 50% in rats (Keyhani et al.,
1997; Kimbell et al., 1997), one can question the importance of
olfactory nerve translocation for UFP in humans. In addition,
rats are obligatory nose breathers, whereas humans are mixed
oro-nasal/nasal breathers. However, although only 15% of the
total rat nasal airow is directed to their olfactory mucosa, it is
10% in humans (Keyhani et al., 1997; Kimbell et al., 1997), only
one-third less. Moreover, as pointed out before, the rest of the
nasal mucosa is supplied by sensory nerve endings of the oph-
thalmic and maxillary branches of the trigeminus nerve, which
can also function as a translocation pathway for solid UFP as
discussed earlier (Hunter & Dey, 1998). Some of the trigem-
inal sensory nerve endings in the nasal epithelium also have
branches reaching directly into the olfactory bulb (Schaefer
et al., 2002).
Classical clearance mechanisms for inhaled particles de-
posited in the nasal compartment of the respiratory tract are
via mucociliary transport (toward the oropharynx in the poste-
rior part of the nose, and through sneezing and nose blowing.
Biosoluble components of particles deposited in this region are
subjected to dissolution and subsequent absorption into blood
(U.S. EPA, 1996; Schlesinger et al., 1997). Uptake by sensory
nerve endings (olfactory, trigeminus), which has been the focus
of this discussion, constitutes a clearance pathway to extrapul-
monary organs, that is, the CNS, which has not been appropri-
ately recognized so far, despite several recent reports describing
ULTRAFINE PARTICLE TRANSLOCATION TO THE BRAIN
443
the passage of metals along this route after inhalation or nasal
instillation of biosoluble metal compounds (Gianutsos et al.,
1997; Tj¨alve & Henriksson, 1999; Brenneman et al., 2000;
Dorman et al., 2002). Dorman et al. (2002) pointed out most
recently the potential importance of this pathway for brain deliv-
ery of Mn derived from soluble and slowly soluble inhaled Mn
compounds. That this delivery route exists as well for solid UFP
is clearly demonstrated by the earlier work on olfactory uptake
and transport of 50-nm gold particles and 30-nm virus parti-
cles described above (Bodian & Howe, 1941; Howe & Bodian,
1941; De Lorenzo, 1970); also, our present result with 36-nm
insoluble elemental carbon particles is consistent with this same
translocation mechanism and extends the earlier ndings from
nasally instilled to inhaled UFP. Thus, the olfactory route to
the CNS and uptake into other sensory nerve endings in the ex-
trathoracic and tracheobronchial region should be recognized as
mechanisms for extrapulmonary translocation of soluble metal
compounds and UFP (Figure 3), in addition to the classical
clearance mechanism in the nasal area already mentioned.
Neuronal uptake and translocation in the respiratory tract
could be especially important for the smallest UFP below 10
20 nm generated at very high number concentrations in the
FIG. 3. Suggested neuronal translocation pathways in hu-
mans for solid nanosized particles and for soluble components
of larger particles that have been demonstrated in rodents and
nonhuman primates. These include uptake into nerve endings
embedded in mucosa of nasal (a, olfactory; b, trigeminal nerves)
and tracheobronchial (c, afferent vagal nerves) region. The bi-
ological/toxicological importance of these pathways and their
contribution to particle clearance vis-`a-vis the classical clear-
ance pathways of mucociliary and phagocytic cell transport,
dissolution, diffusion, and protein binding remain to be deter-
mined. Drawing courtesy of Dr. J. Harkema.
ambient air from trafc-related sources and photochemical nu-
cleation events (Kittelson, 1998; McMurry et al., 2000; Woo
et al., 2001), or for newly developed nanomaterials (engineered
nanoparticles of carbon, metals, metal oxides, quantum dots
etc.) should they become airborne and be inhaled. The smaller
the inhaled UFP, the more of them could be subjected to a neu-
ronal clearance pathway in the nose, because nasal deposition
increases with decreasing UFP size. Below a size of 5 nm, nasal
deposition efciency rises rapidly and eventually approaches
100%, whereas particles above 30 nm have only a less than 10%
nasal deposition probability (Figure 1); (ICRP, 1994; Cheng
et al., 1996; Swift et al., 1992). Since the smaller ambient
UFP consist of very little elemental but mostly organic car-
bon (Kittelson, 1998), their fate after deposition depends most
likely on their lipid or water dissolution rate; that is, how long
after deposition will these particles maintain their particulate
state: are they dissolving quickly before translocation, during
translocation, or once they have reached CNS structures? Even
if dissolution occurs during the translocation process, antero-
grade translocation and retrograde translocation of lipids and
organic material along axons of neurons have been shown to
take place as well (Grafstein & Foreman, 1980).
While the early studiesshowing nasal to olfactory bulb
translocation of 30-nm virus and 50-nm gold particles in non-
human primatesprove that this transfer mechanism operates
in primates, the signicance for humans still needs to be es-
tablished. In general, there are many unanswered questions re-
garding sensory nerve uptake and transport of inhaled UFP de-
posited on the mucosa of the olfactory nasal region and at other
sites of the respiratory tract, including: What is the mechanism
of uptake: receptor-mediated endocytosis, pinocytosis, axonal
transport? How do physicochemical characteristics of UFP and
their surfaces inuence uptake and translocation? How far into
the CNSbeyond he olfactory bulb to striatal, frontal cortex,
and other structurescan UFP be translocated? To what extent
is this pathway operable for volatile and semivolatile organics
as major constituents of ambient UFP below 20 nm? Are there
toxicological consequences? A recent study described signi-
cant inammatory changes of the olfactory mucosa, olfactory
bulb, and cortical and subcortical structures in dogs from a heav-
ily polluted area in Mexico City, changes that were not seen in
dogs from a less polluted control city (Calderon-Garciduenas
et al., 2002). While this study was not designed to investigate a
nasal-CNS transfer route of inhaled ultrane particulate air pol-
lutants, the observed inammatory changes are consistent with
such mechanism. Is UFP uptake limited to particles <100 nm,
or does this mechanism also operate for larger particles? Ax-
onal diameter certainly will impose a limitfor example, ol-
factory la in the squirrel monkey measure 200 nm in diameter
(DeLorenzo, 1970). Anterograde and retrograde transport of
even larger particles directly injected into a giant axon has been
observed (Adams & Bray, 1983), with one suggested mecha-
nism being cytoskeletal movement along an escalator provided
by axonal and dendritic microtubuli (Hirokawa, 1998; Ligon
444 G. OBERD
¨
ORSTER ET AL.
& Steward, 2000) via kinesin and cytoplasmic dynein motor
proteins (Vale et al., 1985; Paschal et al., 1987). Protein coat-
ing of UFP after deposition may be necessary for this neuronal
translocation pathway. In addition, the vascular route of translo-
cation, that is, UFP crossing the BBB after entering the vascular
compartment, needs to be explored as well. Answers to these
questions of are interest not only for ambient UFP but also for
the growing eld of biomedical use of engineered nanoparticles
and quantum dots with respect to their kinetics when adminis-
tered in vivo as drug delivery devices or as biosensors.
We conclude from our studies that inhaled ultrane carbon
particles are to a signicant extent translocated to the CNS.
Our ndings are consistent with retrograde dendritic and an-
terograde axonal transport via the olfactory nerve, a pathway
whose existence in non-human primates and in rodents has been
proven in earlier nasal instillation studies for solid UFP as well
as for soluble metal compounds. This constitutes a direct portal
of entry for UFP into the CNS, circumventing the tight blood
brain barrier. This not generally recognized clearance pathway
from the nasal mucosa to the CNS could be of signicance
for induction of neurotoxic effects following acute or chronic
inhalation exposures to environmental or occupational UFP. Po-
tential long-term effects of their accumulation in the olfactory
bulb and translocation to other regions of the CNS represent a
new eld in PM research.
REFERENCES
Adams, R. J., and Bray, D. 1983. Rapid transport of foreign particles
microinjected into crab axons. Nature 303:718720.
Arvidson, B. 1994. A review of axonal transport of metal. Toxicology
88:114.
Asgharian, B., Miller, F. J., Subramaniam, R. P., Dosimetry software
to predict particle deposition in humans and rats. CIIT Activities,
Vol 19, No. 3, March, 1999.
Bodian, D., and Howe, H. A. 1941. The rate of progression of po-
liomyelitis virus in nerves. Bull. Johns Hopkins Hosp. LXIX(2):79
85.
Brand, W. A. 1996. High precision isotope ratio monitoring techniques
in mass spectrometry. J. Mass Spectrom. 31:225235.
Brenneman, K. A., Wong, B. A., Buccellato, M. A., Costa, E. R., Gross,
E. A., and Dorman, D. C. 2000. Direct olfactory transport of inhaled
manganese (
54
MnCl
2
) to the rat brain. Toxicokinetic investigations
in a unilateral nasal occlusion model. Toxicol. Appl. Pharmacol.
169:238248.
Brown, J. S., Zeman, K. L., and Bennett, W. D. 2002. Ultrane particle
deposition and clearance in the healthy and obstructed lung. Am. J.
Respir. Crit. Care Med. 166:12401247.
Calderon-Garciduenas, L., Azzarelli, B., Acune, H., Garcia, R.,
Gambling, T. M., Osnaya, N., Monroy, S., Tizapantzi, M. D. R.,
Carson, J. L., Villarreal-Calderon, A., and Rewcastle, B. 2002. Air
pollution and brain damage. Toxicol. Pathol. 30(3):373389.
Cheng, Y.-S., Yeh, H.-C., Guilmette, R. A., Simpson, S. Q., Cheng,
K. H., and Swift, D. L. 1996. Nasal deposition of ultrane particles
in human volunteers and its relationship to airway geometry. Aerosol
Sci. Technol. 25:274291.
CRC Press. 2000. CRC handbook of chemistry & physics. A ready-
reference book of chemical and physical data, 81st ed. Boca Raton,
FL: CRC Press.
De Lorenzo, A. J. D. 1970. The olfactory neuron and the blood
brain barrier. In Taste and smell in vertebrates. eds. G. E. W.
Wolstenholme and J. Knight, pp. 151176. CIBA Foundation Sym-
posium Series. J.&A. Churchill, London.
Dorman, D. C., Brenneman, K. A., McElveen, A. M., Lynch, S. E.,
Roberts, K. C., and Wong, B. A. 2002. Olfactory transport: A direct
route of delivery of inhaled manganese phosphate to the rat brain.
J. Toxicol. Environ. Health A 65(20):14931511.
Gerde, P., Cheng, Y. S., and Medinsky, M. A. 1991. In vivo deposition
of ultrane aerosols in the nasal airway of the rat. Fundam. Appl.
Toxicol. 16:330336.
Gianutsos, G., Morrow, G. R., and Morris, J. B. 1997. Accumulation of
manganese in rat brain following intranasal administration. Fundam.
Appl. Toxicol. 37:102105.
Grafstein, B., and Forman, D. S. 1980. Intracellular transport in neu-
rons. Physiol. Rev. 60(4):11671283.
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. R.,
Kivman, G. Y., and Kreuter, J. 1999. Signicant transport of dox-
orubicin into the brain with polysorbate 80-coated nanoparticles.
Pharm. Res. 16(10):15641569.
Hirokawa, N. 1998. Kinesin and dynein superfamily proteins
and the mechanism of organelle transport. Science 279:519
526.
Howe, H. A., and Bodian, D. 1941. Poliomyelitis in the chim-
panzee: A clinicalpathological study. Bull. Johns Hopkins Hosp.
LXIX(2):149182.
Hunter, D. D., and Dey, R. D. 1998. Identication and neuropeptide
content of trigeminal neurons innervating the rat nasal epithelium.
Neuroscience 83(2):591599.
Hunter, D. D., and Undem, B. J. 1999. Identication of substance
P content of vagal afferent neurons innervating the epithelium of
the guinea pig trachea. Am. J. Respir. Crit. Care Med. 159:1943
1948.
ICRP. 1992. International Commission on Radiological Protection,
No. 23, Report of the Task Group on Reference Man. New York:
Pergamon Press.
ICRP. 1994. Human respiratory tract model for radiological protection.
Ann. ICRP 24(13). ICRP publication 66.
Illum, L. 2000. Transport of drugs from the nasal cavity to the cen-
tral nervous system. European Journal of Pharmaceutical Sciences
11:118.
Katz, L. C., Burkhalter, A., and Dreyer, W. J. 1984. Fluorescent latex
microspheres as a retrograde neuronal marker for in vivo and in vitro
studies of visual cortex. Nature 310:498500.
Keyhani, K., Scherer, P. W., and Mozell, M. M. 1997. A numerical
model of nasal odorant transport for the analysis of human olfaction.
J. Theor. Biol. 186:279301.
Kimbell, J. S., Godo, M. N., Gross, E. A., Joyner, D. R., Richardson,
R. B., and Morgan, K. T. 1997. Computer simulation of inspiratory
airow in all regions of the F344 rat nasal passages. Toxicol. Appl.
Pharmacol. 145:388398.
Kittelson, D. V. 1998. Engines and nanoparticles: A review. J. Aerosol
Sci. 29(5,6):575588.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K.,
Koch-Brandt, C., and Alyautdin, R. 2002. Apolipoprotein-mediated
ULTRAFINE PARTICLE TRANSLOCATION TO THE BRAIN
445
transport of nanoparticles-bound drugs across the bloodbrain bar-
rier. J. Drug Targeting 10(4):317325.
Kreyling, W. G., Semmler, M., Erbe, F., Mayer, P., Takenaka, S.,
Schulz, H., Oberd¨orster, G., and Ziesenis, A. 2002. Ultrane in-
soluble iridium particles are negligibly translocated from lung ep-
ithelium to extrapulmonary organs. J. Toxicol. Environ. Health A
65(20):15131530.
Ligon, L. A., and Steward, O. 2000. Movement of mitochondria in
the axons and dendrites of cultured hippocampal neurons. J. Comp.
Neurol. 427:340350.
McMurry, P. H., Woo, K. S., Weber, R., Chen, D.-R., and Pui, D. Y.
H. 2000. Size distributions of 3 to 10 nm atmospheric particles: Im-
plications for nucleation mechanisms. Philos. Trans. R. Soc. Lond.
Ser. A 358:26252642.
Muldoon, L. L., Pagel, M. A., Kroll, R. A., Roman-Goldstein, S., Jones,
R. S., and Neuwelt, E. A. 1999. A physiological barrier distal to the
anatomic bloodbrain barrier in a model of transvascular delivery.
Am. J. Neuroradiol. 20:217222.
Nemmar, A., Hoet, P. H. M., Vanquickenborne, B., Dinsdale, D.,
Thomeer, M., Hoylaerts, M. F., Vanbilloen, H., Mortelmans, L.,
Nemery, B. 2002. Passage of inhaled particles into the blood circu-
lation in humans. Circulation 105:411414.
Oberd¨orster, G., Finkelstein, J. N., Johnston, C., Gelein, R., Cox, C.,
Baggs, R., and Elder, A. C. P. 2000. HEI research report: Acute
pulmonary effects of ultrafine particles in rats and mice. Research
Report 96, August. Health Effects Institute, www.healtheffects.
org/pubs-research.htm
Oberd¨orster, G., Sharp, Z., Atudorei, V., Elder A., Gelein, R., Lunts, A.,
Kreyling, W., and Cox, C. 2002. Extrapulmonary translocation of
ultrane carbon particles following whole-body inhalation exposure
of rats. J. Toxicol. Environ. Health A 65(20):15311543.
Paschal, B. M., Shpetner, H. S., and Vallee, R. B. 1987. MAP 1C is
a microtubule-activated ATP-ase which translocates microtubules
in vitro and has dynein-like properties. J. Cell Biol. 105:12731282.
Pekkanen, J., Peters, A., Hoek, G., Tiittanen, P., Brunekreef, B., de
Hartog, J., Heinrich, J., Ibald-Mulli, A., Kreyling, W. G., Lanki, T.,
Timonen, K. L., and Vanninen, E. 2002. Particulate air pollution and
risk of ST-segment depression during repeated submaximal exercise
tests among subjects with coronary heart disease. The exposure
and risk assessment for ne and ultrane particles in ambient air
(ULTRA) study. Circulation 106:933938.
Penttinen, P., Timonen, K. L., Tiittanen, P., Mirme, A., Ruuskanen, J.,
and Pekkanen, J. 2001. Ultrane particles in urban air and respi-
ratory health among adult asthmatics. Euro. Respir. J. 17(3):428
435.
Peters, A., Wichmann, H. E., Tuch, T., Heinrich, J., and Heyder,
J. 1997a. Respiratory effects are associated with the number of
ultrane particles. Am. J. Respir. Crit. Care Med. 155:1376
1383.
Peters, A., Doring, A., Wichmann, H.-E., and Koenig, W. 1997b. In-
creased plasma viscosity during an air pollution episode: A link to
mortality? Lancet 349(9065):15821587.
Schaefer, M. L., Bottger, B., Silver, W. L., and Finger, T. E. 2002.
Trigeminal collaterals in the nasal epithelium and olfactory bulb:
A potential route for direct modulation of olfactory information by
trigeminal stimuli. J. Comp. Neurol. 444(3):221226.
Schlesinger, R. B., Ben-Jebria, A., Dahl, A. R., Snipes, M. B., and
Ultman, J. 1997. Disposition of inhaled toxicants. In Handbook of
human toxicology, ed E. J. Massaro, pp. 493550. Boca Raton, FL:
CRC Press.
Segal, M. B. 2000. The choroid plexuses and the barriers between the
blood and the cerebrospinal uid. Cell. Mol. Neurobiol. 20(2):183
196.
Shankland, W. E. 2001. The trigeminal nerve. Part III: The maxillary
division. Cranio 19(2):7883.
Swift, D. L., Montassier, N., Hopke, P. K., Karpen-Hayes, K., Cheng,
Y.-S., Su, Y. F., Yeh, H. C., and Strong, J. C. 1992. Inspiratory
deposition of ultrane particles in human nasal replicate cast. J.
Aerosol Sci. 23:6572.
Tj¨alve, H., and Henriksson, J. 1999. Uptake of metals in the brain via
olfactory pathways. NeuroToxicity 20(23):181196.
Ueno, M., Akiguchi, I., Hosokawa, M., Kotani, H., Kanenishi, K.,
and Sakamoto, H. 2000. Bloodbrain barrier permeability in the
periventricular areas of the normal mouse brain. Acta Neuropathol.
99:385392.
U.S. Environmental Protection Agency. 1996. Air quality cri-
teria for particulate matter. Research Triangle Park, NC:
National Center for Environmental AssessmentRTP Ofce. Report
EPA/600/P95/001aF-cF.3v.
Vale, R. D., Reese, T. S., and Sheetz, M. P. 1985. Identication of
a novel force-generating protein, kinesin, involved in microtubule-
based motility. Cell 42:3950.
von Klot, S., W¨olke, G., Tuch, T., Heinrich, J., Dockery, D. W.,
Schwartz, J., Kreyling, W. G., Wichmann, H. E., and Peters, A.
2002. Increased asthma medication use in association with ambient
ne and ultrane particles. Eur. Respir. J. 20:691702.
Wichmann, H.-E., Spix, C., Tuch, T., W¨olke, G., Peters, A., Heinrich,
H., Kregling, W. G., and Heyder, J. 2000. Daily mortality and fine
and ultrafine particles in Erfurt, Germany. Part I: Role of particle
number and particle mass. Health Effects Institute Research Report
No. 98, November.
Woo, K.-S., Chen, D.-R., Pui, D. Y. H., and McMurry, P. H. 2001.
Measurement of Atlanta aerosol size distributions: Observations of
ultrane particle events. Aerosol Sci. Technol. 34:7587.
... The first proposed model stipulates that these effects stem from the direct impact of nasally inhaled particles or chemical constituents with both neurons and non-neuronal glial cells in the brain. This impact is thought to occur via translocation along olfactory neurons to the olfactory bulb [23][24][25] . Olfactory sensory neurons have a diameter of~200 nm 26 , potentially allowing ultrafine particles (≤ 100 nm) 27 to translocate through this process. ...
Article
Full-text available
Recent evidence suggests short-term exposure to particulate matter (PM) air pollution can impact brain function after a delay period. It is unknown whether effects are predominantly due to the olfactory or lung-brain pathways. In this study 26 adults (Mage = 27.7, SDage = 10.6) participated in four conditions. They were exposed to either high PM concentrations or clean air for one hour, using normal inhalation or restricted nasal inhalation and olfaction with a nose clip. Participants completed four cognitive tests before and four hours after exposure, assessing working memory, selective attention, emotion expression discrimination, and psychomotor vigilance. Results showed significant reductions in selective attention and emotion expression discrimination after enhanced PM versus clean air exposure. Air quality did not significantly impact psychomotor vigilance or working memory performance. Inhalation method did not significantly mediate effects, suggesting that short-term PM pollution affects cognitive function through lung-brain mechanisms, either directly or indirectly.
Preprint
Full-text available
Coal-to-gas (CTG) policies are important energy transformation strategies to address air pollution issues, but how well it improves atmospheric Lead (Pb) pollution remains poorly understood. By the end of 2018, Beijing had achieved coal-free in urban and plain areas. The mixing state and atmospheric chemical processes of Pb-rich particles in Beijing were monitored using a single particle aerosol mass spectrometry (SPAMS) during 2019. Based on a large dataset of mass spectra, this study find that the number fractions of Pb-rich particles, as well as two types of Pb-rich particles (K-Na-EC and K-OC) related to coal combustion during heating period, show lower than those after the heating period. Based on concentration-weighted trajectory plots, the results indicate that lead aerosols mainly derive from the transmission of surrounding provinces. Lead nitrate is one of the important forms of lead in aerosol particles, most contributed by photo-chemical reactions in spring, fall, and winter. Due to the decomposition of nitrate during high temperatures, the aqueous reactions mechanism contributes more to lead nitrate in summer. These results improve our understanding of the seasonal distribution, formation mechanisms, and influencing factors of toxic Pb-containing particles after CTG.
Article
Full-text available
Peat fires emit large quantities of particles and gases, which cause extensive haze events. Epidemiological studies have correlated wildfire smoke inhalation with increased morbidity and mortality. Despite this, uncertainties surrounding...
Article
Full-text available
Very large and very small particles most often deposit in the nasal airways. Human volunteers have often been used in deposition studies using particles > 0.5 μm, whereas physical airway models have been used in studies of ultrafine particle deposition. Studies in airway models provide large data sets with which to evaluate the deposition mechanism, while in vivo deposition data are needed to validate results obtained with nasal models. Four adult male, nonsmoking, healthy human volunteers (ages 36–57 yr) participated in this study. Deposition was measured in each subject at constant flow rates of 4, 7.5, 10, and 20 L min . Monodisperse silver particles (5, 8, and 20 nm) and polystyrene latex particles (50 and 100 nm) were used. Each subject held his breath for 30–60 sec, during which time, the aerosol was drawn through the nasal airway and exhausted through a mouth tube. Aerosol concentrations in the intake and exhaust air were measured by an ultrafine condensation particle counter. The deposition efficiency in the nasal airway was calculated taking into account particle losses in the mask, mouth tube, and transport lines. Our results were consistent with the turbulent diffusional deposition model previously established from studies using nasal airway casts. However, nasal deposition varied widely among the four subjects. From magnetic resonance imaging data of in vivo nasal airway dimensions for the subjects in this study, we calculated the mean cross-sectional area ([Abar]c), mean perimeter ([Pbar]r), and total surface area (As) of the individual nasal passages. The turbulent diffusional deposition model was extended to provide a relationship between deposition efficiency and nasal airway dimensions. Our results suggested that deposition can be correlated using the parameter of (As/[Abar]c)([Pbar]r). This information indicates a higher nasal deposition for a person with a smaller cross-sectional area, larger surface area, and larger perimeter. This approach has significant potential for future research in the area of intersubject variability of aerosol and vapor deposition.
Article
As part of EPRI's Aerosol Research Inhalation Epidemiology Study (ARIES), measurements of aerosol size distributions in the 3 nm to 2 m diameter range were carried out over a 24 month period beginning August 1998 in Atlanta, GA. An automated fine particle sampling system was developed for this study. The sampling system utilizes a nano-scanning mobility particle sizer (3 nm ppm), and a laser particle counter (0.1 m m). Five complete size distributions are obtained every hour. This paper describes the data collected in the first 13 month period. The year-long data provide detailed information on temporal variations of aerosol size distributions. Our measurements show that particle number concentrations tend to be higher on weekdays than on weekends. Concentrations of particles in the 10-100 nm and 100-2000 nm diameter ranges are higher at night than during the daytime and tend to reach their highest values during morning rush hour. Concentrations of 4-10 nm particles were elevated during rush hour when temperatures were 2 were observed during all three types of events. NO was typically depleted during the 3-10 nm events and was more likely to be elevated during the 10-35 and 35-45 nm events. The sources of these particles are not yet known.
Article
The formation of new atmospheric particles by gas–to–particle conversion leads to enhanced concentrations of nanoparticles. We have studied the formation and growth of new particles in urban Atlanta and in the remote atmosphere in locations rangin from the North Pole to Mauna Loa, Tasmania and the South Pole. Key to this work was our development of new measurement technique for freshly formed nucleation mode particles between 3 and 10 nm. In this paper we show that measured aerosol size distribution in the 3–10 nm diameter range often increase with decreasing size down to our minimum detectable size of 3 nm, presumabl because nucleation was occurring during the measurement. Furthermore, we show that the Atlanta nucleation mode size distribution are consistent with a collision–controlled nucleation process in which accommodation coefficients for all collisions betwee condensing molecules and molecular clusters and between molecular clusters are assumed to be equal to one, and in which evaporatio from molecular clusters is neglected, as would be expected for a highly supersaturated vapour.
Article
The deposition of particles in replicate cast models of the human nasal cavity has been measured in three different laboratories for a range of particle sizes from 0.6 to 200 nm. The results of these measurements on four different casts can be fit by a single equation of the form where η is the fraction of particles deposited in the nasal cavity, Q is the volumetric flow rate (1 min−1), D is the particle diffusion coefficient (cm2s−1), and b is found to be 12.65 ± 0.17. The measurements were conducted over a range of flow rates from 1.4 to 28.71 min−1 (501 min−1 for sizes from 4.6 to 200 nm) using radon and thoron decay product aerosols as well as larger ultrafine particles. These results thus represent a current best estimate of the diffusional deposition of ultrafine particles in the human nasal cavity.
Article
Most of the particle number emitted by engines is in the nanoparticle range, Dp<50 nm, while most of the mass is in the accumulation mode, nm, range. Nanoparticles are typically hydrocarbons or sulfate and form by nucleation during dilution and cooling of the exhaust, while accumulation mode particles are mainly carbonaceous soot agglomerates formed directly by combustion. Emission standards on diesel engines have led to dramatic reductions in particle mass emitted. However, a new HEI study shows that some low-emission diesel engines emit much higher concentrations of nanoparticles than older designs and other low-emission designs. Many recent studies suggest that at similar mass concentrations; nanometer size particles are more dangerous than micron size particles. This has raised questions about whether nanoparticle (number based) emission standards should be imposed. Unlike mass, number is not conserved. It may change dramatically by nucleation and coagulation during dilution and sampling, making it very difficult to design a standard. Furthermore, if nanoparticles are a problem, spark ignition engines may also have to be controlled.